South Denver Wellness by Scott McDoniel, PhD, FACN, FOS comes to the south Denver metro area. Starting June, 2011 Dr. McDoniel will begin seeing patients needing clinical weight loss, nutrition therapy, and behavioral counseling. Dr. McDoniel will partner with medical providers by providing these wellness services in their practices.
Friday, May 20, 2011
Thursday, March 24, 2011
Exercise and Cellulite
We all know what cellulite looks like, but misconceptions prevail. The first thing you should know is that, in the true medical sense, cellulite is simply plain old fat. Yet it does have one defining characteristic - a dimpled, cottage-cheese, orange-peel look.
Here's why: Everybody has connective tissue that separates fat cells into compartments. While men tend to have horizontal or crisscross patterns to those compartments, women have a honeycomb appearance, giving fat a greater chance to protrude or bulge, hence the cottage-cheese effect.
As a result, women are more likely to develop cellulite than men, mainly around the hips and thighs. However, men can develop the condition, too. Although cellulite becomes more noticeable with age, largely because the skin gets thinner over time, it generally strikes individuals in their 30s.
Thursday, February 3, 2011
FDA Rejects Another Weight Loss Drug
It is becoming common practice for the Food and Drug Administration (FDA) to reject applications for new weight loss drugs. Over the past year, the FDA rejected applications for three anti-obesity medications. This week, the FDA rejected the application for Contrave. Contrave is a combination of an antidepressant and an anti-addiction drug to curb
appetite. Early studies demonstrate modest weight-loss benefits (i.e., approximately 4.5% weight loss).
However, FDA scientists
and safety advocates were critical of the data indicating Orexigen, Contrave's manufacturer, enrolled a limited number of elderly
patients or patients with a history of heart disease in its trials,
making it difficult to determine the drug’s safety in patients who are
likely to need it most.
Subscribe to:
Posts (Atom)